Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair
Status:
Recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
A multicenter, single-dose study in children 12 to <17 years of age, 6 to <12 years of age,
and 2 to <6 years of age who are scheduled for elective open inguinal hernia repair.
Enrollment in this study will start with the oldest age group (12 to <17 years) and will
continue in a stepwise fashion until appropriate doses are established for all 3 pediatric
age groups (12 to <17 years, 6 to <12 years, 2 to <6 years).